Viking Therapeutics
  • Home
  • About
    • Overview
    • Management
    • Board of Directors
    • Careers
  • Pipeline
    • Overview
    • Metabolic Disease Programs
      • VK2809 (NASH)
      • VK2735 (Metabolic Disorders)
    • Rare Disease Program
      • VK0214 (X-ALD)
    • Other Pipeline Programs
      • VK5211 (Hip Fracture, Muscle Wasting)
      • VK0612 (Type 2 Diabetes)
      • VK1430 (Hypertriglyceridemia, NASH)
      • EPOR Agonist Program (Anemia)
  • Investors & Media
    • Overview
    • Stock Information
    • News & Events
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • Corporate Presentation
  • Contact

    SEC Filings

    Investors

    • Overview
    • Stock Information
    • News & Events
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • Corporate Presentation

    NASDAQVKTX
    YearTrailing 12-MonthsCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014
    ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
    FormDescriptionDateFormat
    10-KAnnual report which provides a comprehensive overview of the company for the past yearMar 21, 2017Open Annual report which provides a comprehensive overview of the company for the past year in HTML.Open Annual report which provides a comprehensive overview of the company for the past year in DOC file.Open Annual report which provides a comprehensive overview of the company for the past year in PDF file.Open Annual report which provides a comprehensive overview of the company for the past year in XLS file.Open Annual report which provides a comprehensive overview of the company for the past year in XBLR Viewer.Open Annual report which provides a comprehensive overview of the company for the past year in XBLR file.

     

     

    viking therapeutics

    About

    Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

    Contact

    General Information
    Business Development
    ©2023 Viking Therapeutics
    Terms of Use
    Privacy Policy